Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Public ClinicalTrials.gov record NCT02006641. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To establish efficacy of Idalopirdine as adjunctive therapy to donepezil for symptomatic treatment of patients with mild-to-moderate Alzheimer's disease (AD).
Study identification
- NCT ID
- NCT02006641
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 858 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2014 (Type not available)
- Primary completion
- Dec 2016 (Actual)
- Completion
- Dec 2016 (Actual)
- Last update posted
- Feb 20, 2018
2014 – 2016
United States locations
- U.S. sites
- 48
- U.S. states
- 20
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| US338 | Phoenix | Arizona | — | — |
| US342 | Fayetteville | Arkansas | — | — |
| US322 | Anaheim | California | — | — |
| US305 | Carson | California | — | — |
| US346 | Costa Mesa | California | — | — |
| US327 | Fullerton | California | — | — |
| US315 | Lomita | California | — | — |
| US351 | Oceanside | California | — | — |
| US307 | Redlands | California | — | — |
| US301 | Santa Rosa | California | — | — |
| US337 | New London | Connecticut | — | — |
| US332 | Stamford | Connecticut | — | — |
| US308 | Delray Beach | Florida | — | — |
| US320 | Hallandale | Florida | — | — |
| US347 | Hialeah | Florida | — | — |
| US340 | Lake Worth | Florida | — | — |
| US303 | Miami | Florida | — | — |
| US313 | Miami | Florida | — | — |
| US335 | Naples | Florida | — | — |
| US345 | Orange City | Florida | — | — |
| US309 | Palm Beach Gardens | Florida | — | — |
| US302 | Sunrise | Florida | — | — |
| US304 | Atlanta | Georgia | — | — |
| US360 | Augusta | Georgia | — | — |
| US318 | Decatur | Georgia | — | — |
| US334 | Lake Charles | Louisiana | — | — |
| US350 | Belmont | Massachusetts | — | — |
| US344 | Boston | Massachusetts | — | — |
| US310 | Saint Paul | Minnesota | — | — |
| US321 | Hattiesburg | Mississippi | — | — |
| US330 | Creve Coeur | Missouri | — | — |
| US339 | Paterson | New Jersey | — | — |
| US312 | Staten Island | New York | — | — |
| US316 | Charlotte | North Carolina | — | — |
| US336 | Winston-Salem | North Carolina | — | — |
| US323 | Cincinnati | Ohio | — | — |
| US349 | Cleveland | Ohio | — | — |
| US306 | Columbus | Ohio | — | — |
| US352 | Lakewood | Ohio | — | — |
| US333 | Oklahoma City | Oklahoma | — | — |
| US314 | Allentown | Pennsylvania | — | — |
| US324 | Pittsburgh | Pennsylvania | — | — |
| US341 | Pittsburgh | Pennsylvania | — | — |
| US325 | Reading | Pennsylvania | — | — |
| US319 | Port Royal | South Carolina | — | — |
| US356 | Cordova | Tennessee | — | — |
| US343 | Fort Worth | Texas | — | — |
| US354 | Houston | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 114 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02006641, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 20, 2018 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02006641 live on ClinicalTrials.gov.